Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600529.SS Stock Summary
Top 10 Correlated ETFs
600529.SS
In the News
600529.SS Financial details
Company Rating
Buy
Market Cap
17.45B
Income
681.91M
Revenue
4.63B
Book val./share
10.73
Cash/share
3.78
Dividend
0.3
Dividend %
1.08%
Employees
6.41K
Optionable
No
Shortable
Yes
Earnings
28 Apr 2022
P/E
27.2
Forward P/E
-
PEG
29.92
P/S
3.99
P/B
2.6
P/C
7.36
P/FCF
-984.05
Quick Ratio
2.33
Current Ratio
2.95
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
1.08
EPS next Y
-
EPS next Q
-
EPS this Y
4.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
11.41%
Revenue last 5Y
10.13%
Revenue Q/Q
-4.11%
EPS Q/Q
32%
-
-
-
-
SMA20
6%
SMA50
-0.07%
SMA100
10.03%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
10%
ROC
0.1%
Gross Margin
26%
Oper. Margin
15%
Profit Margin
15%
Payout
-
Shs Outstand
663.61M
Shs Float
532.16M
-
-
-
-
Target Price
-
52W Range
23.23-32.97
52W High
-13.09%
52W Low
+20.91%
RSI
69.68
Rel Volume
1.78
Avg Volume
4.62M
Volume
8.23M
Perf Week
6.67%
Perf Month
10.01%
Perf Quarter
7.96%
Perf Half Y
1.46%
-
-
-
-
Beta
0.542315
-
-
Volatility
0.77%, 1%
Prev Close
-0.96%
Price
27.81
Change
2.73%
600529.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 4.33 | 5.02 | 5.77 | 6.49 | 6.98 | |
Net income per share | 0.6 | 0.77 | 0.95 | 0.99 | 1.03 | |
Operating cash flow per share | 0.78 | 1.01 | 0.95 | 1.26 | 0.42 | |
Free cash flow per share | 0.2 | 0.01 | 0.05 | -0.1 | -0.76 | |
Cash per share | 1.4 | 2.55 | 2.29 | 2 | 4.09 | |
Book value per share | 5.91 | 6.49 | 7.16 | 7.82 | 11.6 | |
Tangible book value per share | 5.65 | 6.2 | 6.82 | 7.49 | 11.16 | |
Share holders equity per share | 5.91 | 6.49 | 7.16 | 7.82 | 11.6 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 7.93B | 16.47B | 29.8B | 26.21B | 17.05B | |
Enterprise value | 7.1B | 15.41B | 28.66B | 25.33B | 15.7B | |
P/E ratio | 22.15 | 35.9 | 52.79 | 44.34 | 27.57 | |
Price to sales ratio | 3.07 | 5.5 | 8.69 | 6.76 | 4.07 | |
POCF ratio | 17.03 | 27.49 | 52.64 | 34.93 | 67.53 | |
PFCF ratio | 67.02 | 2.24K | 967.07 | -445.64 | -37.2 | |
P/B Ratio | 2.25 | 4.26 | 7 | 5.61 | 2.45 | |
PTB ratio | 2.25 | 4.26 | 7 | 5.61 | 2.45 | |
EV to sales | 2.75 | 5.15 | 8.36 | 6.54 | 3.75 | |
Enterprise value over EBITDA | 11.52 | 21.26 | 31.14 | 26.23 | 15.06 | |
EV to operating cash flow | 15.24 | 25.72 | 50.64 | 33.75 | 62.2 | |
EV to free cash flow | 59.97 | 2.09K | 930.34 | -430.59 | -34.26 | |
Earnings yield | 0.05 | 0.03 | 0.02 | 0.02 | 0.04 | |
Free cash flow yield | 0.01 | 0 | 0 | 0 | -0.03 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -1.35 | -1.46 | -1.23 | -0.92 | -1.29 | |
Current ratio | 2.81 | 2.4 | 2.41 | 1.99 | 3.02 | |
Interest coverage | -284.72 | -342.68 | -293.88 | -253.2 | -273.38 | |
Income quality | 1.3 | 1.31 | 1 | 1.27 | 0.41 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.28 | 0.28 | 0.32 | 0.3 | 0.29 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | |
Intangibles to total assets | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.75 | -0.99 | -0.95 | -1.08 | -2.82 | |
Capex to revenue | -0.13 | -0.2 | -0.16 | -0.21 | -0.17 | |
Capex to depreciation | -2.37 | -3.5 | -2.46 | -3.36 | -2.41 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 8.93 | 10.61 | 12.37 | 13.2 | 16.39 | |
ROIC | 0.11 | 0.13 | 0.14 | 0.13 | 0.09 | |
Return on tangible assets | 0.08 | 0.09 | 0.1 | 0.1 | 0.07 | |
Graham Net | 1.04 | 1.91 | 1.93 | 1.41 | 4.1 | |
Working capital | 1.93B | 1.75B | 1.84B | 1.66B | 3.56B | |
Tangible asset value | 3.37B | 3.7B | 4.05B | 4.47B | 6.7B | |
Net current asset value | 1.89B | 1.7B | 1.78B | 1.6B | 3.5B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 778.62M | 784.12M | 902.18M | 1.15B | 1.45B | |
Average payables | 758.01M | 899.05M | 995.98M | 1.22B | 1.43B | |
Average inventory | 558.27M | 625.31M | 714.28M | 813.47M | 1.04B | |
Days sales outstanding | 112.24 | 94.34 | 109.8 | 119.17 | 142.06 | |
Days payables outstanding | 176.92 | 192.59 | 159.62 | 192.12 | 168.95 | |
Days of inventory on hand | 126.03 | 131.34 | 120.09 | 117.46 | 144.17 | |
Receivables turnover | 3.25 | 3.87 | 3.32 | 3.06 | 2.57 | |
Payables turnover | 2.06 | 1.9 | 2.29 | 1.9 | 2.16 | |
Inventory turnover | 2.9 | 2.78 | 3.04 | 3.11 | 2.53 | |
ROE | 0.1 | 0.12 | 0.13 | 0.13 | 0.09 | |
Capex per share | -0.58 | -0.99 | -0.9 | -1.36 | -1.18 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 1.59 | 1.72 | 2 | 1.86 | 1.78 | |
Net income per share | 0.29 | 0.29 | 0.21 | 0.25 | 0.33 | |
Operating cash flow per share | 0.29 | 0.29 | 0.21 | 0.25 | 0.31 | |
Free cash flow per share | 0.02 | -0.05 | 0.02 | 0.05 | -0.06 | |
Cash per share | 1.57 | 1.11 | 4.09 | 3.79 | 3.78 | |
Book value per share | 8.18 | 8.48 | 11.6 | 10.7 | 10.73 | |
Tangible book value per share | 7.73 | 8.03 | 11.16 | 10.31 | 10.34 | |
Share holders equity per share | 8.18 | 8.48 | 11.6 | 10.7 | 10.73 | |
Interest debt per share | 0.01 | 0.07 | 0.02 | 0.01 | 0.02 | |
Market cap | 16.47B | 17.07B | 17.05B | 17.48B | 18.13B | |
Enterprise value | 15.68B | 16.46B | 15.7B | 16.11B | 17.18B | |
P/E ratio | 24.41 | 24.68 | 34.51 | 26.25 | 20.7 | |
Price to sales ratio | 17.63 | 16.87 | 14.22 | 14.14 | 15.29 | |
POCF ratio | 97.64 | 98.72 | 138.06 | 105 | 88.15 | |
PFCF ratio | 1.45K | -580.83 | 1.14K | 520.19 | -478.09 | |
P/B Ratio | 3.42 | 3.42 | 2.45 | 2.45 | 2.54 | |
PTB ratio | 3.42 | 3.42 | 2.45 | 2.45 | 2.54 | |
EV to sales | 16.78 | 16.26 | 13.1 | 13.03 | 14.49 | |
Enterprise value over EBITDA | 85.32 | 111.62 | 78 | 84.44 | 61.83 | |
EV to operating cash flow | 92.97 | 95.19 | 127.15 | 96.76 | 83.53 | |
EV to free cash flow | 1.38K | -560.04 | 1.05K | 479.37 | -453.04 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -4.28 | -4.14 | -6.69 | -7.19 | -3.42 | |
Current ratio | 1.93 | 2 | 3.02 | 3.12 | 2.95 | |
Interest coverage | 51.01 | 2.46 | 22.94 | -317.77 | 0 | |
Income quality | 1 | 1 | 1 | 1 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | -0.03 | 0.1 | -0.08 | 0.03 | -0.02 | |
Research and developement to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.93 | -1.17 | -0.88 | -0.8 | -1.18 | |
Capex to revenue | -0.17 | -0.2 | -0.09 | -0.11 | -0.21 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.26 | 7.48 | 7.33 | 7.76 | 8.91 | |
ROIC | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | |
Return on tangible assets | 0.03 | 0.03 | 0.01 | 0.02 | 0.02 | |
Graham Net | 1.17 | 1.07 | 4.1 | 3.94 | 3.8 | |
Working capital | 1.67B | 1.67B | 3.56B | 3.7B | 3.63B | |
Tangible asset value | 4.56B | 4.73B | 6.7B | 6.87B | 6.89B | |
Net current asset value | 1.61B | 1.61B | 3.5B | 3.65B | 3.58B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 1.42B | 1.46B | 1.56B | 1.7B | 1.8B | |
Average payables | 1.34B | 1.37B | 1.41B | 1.39B | 1.32B | |
Average inventory | 1.03B | 1.15B | 1.2B | 1.18B | 1.15B | |
Days sales outstanding | 138.2 | 132.28 | 122.37 | 128.65 | 138.41 | |
Days payables outstanding | 181.14 | 170.61 | 137.92 | 130.45 | 139.41 | |
Days of inventory on hand | 150.92 | 145.69 | 117.69 | 109.59 | 124.46 | |
Receivables turnover | 0.65 | 0.68 | 0.74 | 0.7 | 0.65 | |
Payables turnover | 0.5 | 0.53 | 0.65 | 0.69 | 0.65 | |
Inventory turnover | 0.6 | 0.62 | 0.76 | 0.82 | 0.72 | |
ROE | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | |
Capex per share | -0.27 | -0.34 | -0.18 | -0.2 | -0.37 |
600529.SS Frequently Asked Questions
What is Shandong Pharmaceutical Glass Co., Ltd stock symbol ?
Shandong Pharmaceutical Glass Co., Ltd is a CN stock and trading under the symbol 600529.SS
What is Shandong Pharmaceutical Glass Co., Ltd stock quote today ?
Shandong Pharmaceutical Glass Co., Ltd stock price is $27.81 today.
Is Shandong Pharmaceutical Glass Co., Ltd stock public?
Yes, Shandong Pharmaceutical Glass Co., Ltd is a publicly traded company.